| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d81adb089f68139079c75eded9109cc6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-66 |
| filingDate |
2020-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98c061dffcce30d09e032a27263354e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3923eda8b2a3bdecbc7ef123ee3e42b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392d2680a5154e01f8419df4673a44d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca74c9eecf954b7d5f5bf149f0e00dcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf5defe23931500f089b0b677a4310b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e89c29de896620f82ef93925f2e24f |
| publicationDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020206385-A1 |
| titleOfInvention |
Improved methods and compositions for synthetic biomarkers |
| abstract |
The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells. In some aspects, the present disclosure provides for a method comprising: (a) administering to a subject a composition, wherein the composition induces expression of a biomarker in a diseased cell preferentially over expression of the biomarker in non-diseased cells in the subject such that a relative ratio of the biomarker expressed in the diseased cell over the non-diseased cells is greater than 1.0; (b) detecting the biomarker; and (c) using the biomarker detected in (b) to determine that the subject has the diseased cell at an accuracy of at least 70%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113077448-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034743-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10988521-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11685928-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11142555-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947552-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022165267-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072797-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894812-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401526-B2 |
| priorityDate |
2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |